Sebastian Kramer-Bach
Public Communications Contact bei DEUTSCHE BANK AG
Aktive Positionen von Sebastian Kramer-Bach
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| DEUTSCHE BANK AG | Public Communications Contact | - | - |
| DWS GROUP GMBH & CO. KGAA | Public Communications Contact | 01.09.2022 | - |
| Vertrieb & Marketing | 01.09.2022 | - |
Karriereverlauf von Sebastian Kramer-Bach
Ehemalige bekannte Positionen von Sebastian Kramer-Bach
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| STADA ARZNEIMITTEL | Public Communications Contact | 01.01.2017 | - |
Statistik
International
| Deutschland | 3 |
| Vereinigte Staaten | 2 |
Operativ
| Public Communications Contact | 3 |
| Sales & Marketing | 1 |
Sektoral
| Finance | 3 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| DEUTSCHE BANK AG | Finance |
| DWS GROUP GMBH & CO. KGAA | Finance |
| Private Unternehmen | 1 |
|---|---|
STADA Arzneimittel AG
 STADA Arzneimittel AG Pharmaceuticals: OtherHealth Technology STADA Arzneimittel AG engages in the provision of healthcare and pharmaceutical products. It operates through the following segments: Generics, Consumer Healthcare, and Specialty. The Generics segment produces and distributes generic drugs. The Consumer Healthcare segment includes products such as OTC drugs, nutritional supplements and certain consumer healthcare products such as disinfectants and sunscreen. The Specialty segment includes branded generics, specialty generics, and biosimilars. Its brands include Zoflora, Grippostad, Nizoral, and Shampoo & Ladival. The company was founded on March 14, 1895 and is headquartered in Bad Vilbel, Germany. | Health Technology |
- Börse
- Insiders
- Sebastian Kramer-Bach
- Erfahrung
